Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease
Hemasphere. 2024 Jun 25;8(6):e109. doi: 10.1002/hem3.109. eCollection 2024 Jun. ABSTRACT Mitapivat is an investigational, oral, small-molecule allosteric activator of pyruvate kinase (PK). PK is a …